KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Boston Scientific (BSX) EPS (Basic) (2016 - 2026)

Boston Scientific's EPS (Basic) history spans 18 years, with the latest figure at $0.9 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 95.65% to $0.9 in Q1 2026 year-over-year; TTM through Mar 2026 was $2.41, a 74.64% increase, with the full-year FY2025 number at $1.96, up 55.56% from a year prior.
  • EPS (Basic) hit $0.9 in Q1 2026 for Boston Scientific, up from $0.46 in the prior quarter.
  • Over the last five years, EPS (Basic) for BSX hit a ceiling of $0.9 in Q1 2026 and a floor of $0.07 in Q1 2022.
  • Historically, EPS (Basic) has averaged $0.33 across 5 years, with a median of $0.34 in 2023.
  • Biggest five-year swings in EPS (Basic): plummeted 69.57% in 2022 and later surged 277.78% in 2023.
  • Tracing BSX's EPS (Basic) over 5 years: stood at $0.09 in 2022, then surged by 277.78% to $0.34 in 2023, then rose by 11.76% to $0.38 in 2024, then increased by 21.05% to $0.46 in 2025, then surged by 95.65% to $0.9 in 2026.
  • Business Quant data shows EPS (Basic) for BSX at $0.9 in Q1 2026, $0.46 in Q4 2025, and $0.51 in Q3 2025.